Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.3 USD | +2.49% |
|
+1.42% | -32.57% |
Jun. 24 | JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating | MT |
Jun. 17 | Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.57% | 6.38B | |
+20.95% | 127B | |
+23.00% | 116B | |
+25.15% | 27.69B | |
-19.75% | 19.62B | |
-16.57% | 16.26B | |
-16.56% | 15.49B | |
+11.19% | 14.81B | |
-46.65% | 14.39B | |
+57.74% | 14.11B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics Insider Sold Shares Worth $1,363,712, According to a Recent SEC Filing